The EMJ Podcast: Insights For Healthcare Professionals EMJ

Could clinical hypnosis improve outcomes for patients? Find out with Sarah Partridge, Consultant in Clinical Oncology at Imperial Healthcare NHS Trust, London. In this episode, Jonathan and Partridge discuss how hypnosis can be harnessed in a clinical setting, how it can be normalised, and its impact managing side effects.
Use the following timestamps to navigate our episode!
(00:00)-Introduction
(01:45)-Sarah’s route to clinical oncology
(04:22)-Discovering and implementing hypnosis as a tool
(08:12)-Hypnosis in managing side effects
(12:18)-Hypnosis in clinical scenarios
(16:31)-Tranceform: The era of digital resources
(21:00)-Normalising clinical hypnosis
(24:51)-Hypnosis: A different form of dissociative state

This podcast explores health psychology in gastroenterology. Jonathan and Megan Riehl, University of Michigan, Ann Arbor, USA, discuss brain-gut behavioural therapies, misconceptions surrounding mental health and gastrointestinal conditions, and her book "Mind Your Gut".
Timestamps:
(00:00)-Introduction
(03:28)-Megan’s journal to health psychology
(6:30)-Lifestyle factors and digestive distress
(10:45)-Brain-gut behavioural therapies
(17:00)-Common misconceptions in IBS
(21:34)-The microbiome: feeding your gut
(25:20)-Integrating GI mental health into practice
(29:45)- 'Mind Your Gut'
(35:06)-‘The Gut Health Podcast’
(38:40)-Megan’s three wishes for healthcare
 

Nick Oliver, Wynn Professor of Human Metabolism at Imperial College Healthcare NHS Trust, London, UK, joins Jonathan to discuss all things diabetes, from patient education to awareness for diabetes prevention, as well as research into islet cell transplantation.
Use the following timestamps to navigate our episode!
(00:00)-Introduction
(02:25)-Nick Oliver, playwright
(05:07)-Nick’s ‘origin story’
(07:33)-Acknowledging the current challenges in diabetes treatment, and goals for the future
(11:00)-Patient awareness and education in the treatment and management of diabetes
(15:29)-Technology in aiding diabetes treatment
(19:03)-Quality of life in real-time continuous glucose monitoring in children
(21:49)-The artificial pancreas: where is it now, and where is it going?
(26:12)-Intraocular islet cell transplantation in early-onset diabetic retinopathy
(29:54)-Innovative developments on the horizon
(33:07)-Research on increased glycaemic variability in pregnant females with gastric bypass
(35:43)-The work of the European Association for the Study of Diabetes (EASD)
(37:16)-Three wishes for the future of healthcare

This episode focuses on monogenic diabetes, diabetes research, and inspiring the next generation of nurses. Jonathan is joined by Maggie Shepherd, Honorary Clinical Professor at the University of Exeter Medical School, UK. The pair explore how we can strengthen the research influence of nurses, including the 70@70 programme, as well as Shepherd’s initiatives to encourage a career in nursing and research in nursing.
Use the following timestamps to navigate our episode!
(00:00)-Introduction 
(03:43)-Entering into diabetes research
(04:27)-Monogenic diabetes 
(07:01)-70@70 initiative 
(11:00)-Aster Guardians Global Nursing award
(12.32)-Successes, challenges, and opportunities in monogenic diabetes
(14:48)-Patient care during COVID-19 
(17:30)-‘1 in 6 Billion’ podcast
(19:56)-Inspiring the next generation
(23:09)-Maggie’s wishes for the future of healthcare 

CoMiSS, the “Cow’s Milk related Symptom Score”,  is a valuable resource for healthcare professionals, parents, and carers alike, offering an easy-to-use awareness tool that supports the recognition of cow’s milk-related symptoms in infants and young children.
2024 marks the 10th anniversary of CoMiSS, prompting us to look back at the decade of science and clinical practice behind the tool. The podcast reflects on the tool’s inception, its impact on aiding earlier diagnosis, and its role in evaluating therapeutic interventions for managing symptoms of cow’s milk allergy (CMA).

This podcast episode dives into the screening and management of Duchenne muscular dystrophy, as well as diversity in genetic databases, and treating neuromuscular disorders. Jonathan is joined by Madhuri Hegde, Senior Vice-President & Chief Scientific Officer at Revvity, Inc., to talk about innovation in genomic testing.
Use the following timestamps to navigate our episode!
 
(00:00)-Introduction 
(03:54)-Entering into genomic technologies
(05:13)-Duchenne muscular dystrophy
(10:47)-Revvity and genome sequencing
(13:13)-Ultrarapid genomic testing (urWGS)
(15:18)-LANTERN project
(17:42)-Lack of diversity in genetic databases
(20:06)-New developments in genetics
(22:19)-COVID-19 testing laboratories
(27:27)-Madhuri’s wishes for healthcare